Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #132597 on Biotech Values
DewDiligence
06/25/13 9:34 AM
#163037 RE: floblu14 #132597
Momenta Pharmaceuticals…today announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 8,470,318, entitled "Polypeptides With Enhanced Anti-inflammatory and Decreased Cytotoxic Properties and Related Methods," to The Rockefeller University. Momenta is the exclusive licensee of the patent. The patent claims methods of inhibiting inflammation using intravenous immunoglobulin (IVIG)-derived, sialylated Fc regions and expires in 2028.